Merit Medical to Participate in the Bank of America Healthcare Conference
Rhea-AI Summary
Merit Medical (NASDAQ: MMSI) will participate in the Bank of America 2026 Health Care Conference in Las Vegas, May 12-14, 2026. Management will hold a fireside chat on Tuesday, May 12 at 3:00 PM PT / 6:00 PM ET.
A live audio webcast will be available under the company’s Events section and a replay will remain accessible for approximately 90 days.
Positive
- None.
Negative
- None.
News Market Reaction – MMSI
In the May 8 session, MMSI declined 1.70%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 30 | Q1 2026 earnings | Positive | -9.1% | Strong Q1 growth, higher EPS, asset sale and guidance update. |
| Apr 02 | Earnings date set | Neutral | +0.2% | Announcement of Q1 2026 results release and conference call timing. |
| Apr 01 | View Point acquisition | Positive | -1.0% | Acquisition to expand therapeutic oncology portfolio with OneMark system. |
| Mar 24 | Distribution agreement | Positive | -0.8% | Agreement to offer FDA‑cleared ViaVerte BVNA system for back pain. |
| Mar 16 | Product launch | Positive | -0.2% | US launch of Resilience TTS Esophageal Stent for complex esophageal cases. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent positive operational and strategic news often coincided with flat-to-negative one-day price reactions, indicating a pattern of selling or muted response on good news.
Over recent months, Merit Medical reported solid Q1 2026 results with revenue of $381.9M, higher margins, and updated 2026 revenue guidance of $1.612–$1.634B. It sold DualCap assets for $28M and acquired View Point Medical for about $140M to expand oncology offerings. The company also launched the Resilience TTS Esophageal Stent and entered a distribution agreement for the FDA‑cleared ViaVerte BVNA system. Despite these positives, several announcements saw modest or negative next‑day price moves.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH JORDAN, Utah, May 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that Merit management will participate in the Bank of America 2026 Health Care Conference, to be held in Las Vegas, Nevada, May 12-14, 2026.
The management team will participate in a fireside chat session on Tuesday, May 12th at 3:00 pm Pacific Time / 6:00 pm Eastern Time.
A live audio webcast of the fireside chat will be accessible under the “Events” section of the Company’s investor relations website at Investor Events and Presentations - Merit Medical. A replay of the fireside chat will be available on this same website for approximately 90 days.
ABOUT MERIT MEDICAL
Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,600 people worldwide.
CONTACTS
PR/Media Inquiries
Sarah Comstock
Merit Medical
+1-801-432-2864 | sarah.comstock@merit.com
Investor Inquiries
Mike Piccinino, CFA, IRC
ICR Healthcare
+1-443-213-0509 | mike.piccinino@icrhealthcare.com
